Papers/PMID:23340885
myo-Inositol supplementation and onset of gestational diabetes mellitus in pregnant women with a family history of type 2 diabetes: a prospective, randomized, placebo-controlled study.
Diabetes care2013The record
1 finding · 1 compound · 1 endpoint
What it reported
How to read these marksWhat moved
1 finding
myo-inositol — decreases gestational diabetes mellitus incidence
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“Incidence of GDM was significantly reduced in the myo-inositol group compared with the placebo group: 6 vs. 15.3%, respectively (P = 0.04).”
Quoted verbatim from myo-Inositol supplementation and onset of gestational diabetes mellitus in pregnant women with a family history of type 2 diabetes: a prospective, randomized, placebo-controlled study.. - Study
- RCT
- Dose
- 2 g myo-inositol plus 200 µg folic acid twice a day
- Population
- pregnant outpatients with a parent with type 2 diabetes, treated from the end of the first trimester; folic acid 200 µg twice daily given in both arms
myo-Inositol supplementation and onset of gestational diabetes mellitus in pregnant women with a family history of type 2 diabetes: a prospective, randomized, placebo-controlled study.2013PMID:23340885Permalink